A radioimmunoassay for the measurement of amitriptyline and nortriptyline in serum, saliva, and urine is described. The sensitivity of the assay is such that 0·5 ng/ml of drug can be measured, although the assay does not distinguish between amitriptyline and nortriptyline. Other tricyclic compounds cross-react with the antiserum to varying degrees, but the metabolites of amitriptyline did not significantly cross-react. Total tricyclic compounds were detected in serum and saliva after single oral doses of amitriptyline, although the absorption was slow.
Material and methods

IMMUNISATION PROCEDURE
Three sheep were treated with intramuscular injections of an emulsion of 5 mg immunogen and 3 mg BCG vaccine in 1 ml isotonic saline. The emulsifying REAGENTS agent was 2 ml Marcol 52 adjuvant. 0·5 ml pertussis 3H-imipramine (23 Ci/mmol) was obtained from the vaccine was injected intradermally at the same time. Radiochemical Centre, Amersham, Great Britain, After four weeks a boosting dose of 2 mg immunogen and stored as the purified material in ethanolic was given. This was repeated at four-week intervals solution in the dark at -2ZOC. Storage did not affect for the next two months and thereafter at intervals of the purity, which was periodically checked by TLC approximately six months. Samples of serum were in a solvent system of acetone/chloroform/ammonia. taken from the sheep at different times after the 14C-N-methylnortriptyline (2'13 mCi/mmol) was a boosting doses. With each bleed, the potency of the gift from the Lilly Research Centre.
antisera was investigated. The maximum binding at Non-radioactive tricyclic compounds and their 1/50 dilution and the dilution at which there was a metabolites were kindly donated by Dr A. A. Manian 50 %reduction in total binding were calculated from (US National Institute of Mental Health), May and antibody curves. From these calculations, the anti-Baker (Dagenham, Essex), Boots Company serum obtained nine months after the initial immuni-(Nottingham), Berk Pharmaceuticals (Godalming, sat ion was thoroughly investigated, and used for 221
Measurement of amitriptyline, nortriptyline, and other tricyclic antidepressants have in the past depended mainly on fluorimetry (Dingell et al., 1964) , thin-layer chromatography (Faber et al., 1974) , gasliquid chromatography (Braithwaite and Widdop, 1971; Gifford et al., 1975) , and, more recently, highpressure liquid chromatography (Watson and Stewart, 1977) . Isotope derivatisation techniques (Hammer and Brodie, 1967) have been employed, though usually only for research purposes. Most methods require prior extraction and some form of derivatisation before the samples can be assayed, and are therefore time-consuming. An assay for the tricyclic drugs, which is both sensitive and simple to perform and which avoids the need for extraction, such as radioimmunoassay (RIA), would offer a considerable advantage in the clinical assay of these drugs. This paper describes such a technique.
assay purposes, although later bleeds gave higher titres.
ASSAY PROCEDURE
After preliminary experiments using 14C-N-methylnortriptyline (Aherne et al., 1976) the following procedure was used for the assay of tricyclic antidepressants in body fluid: To LP3 plastic tubes (Luckham) were added 100 JLl of sheep antiserum diluted 1000fold; 100 JLl of patient's sample or standards of nortriptyline or amitriptyline; 200 JLl of O'OSM phosphate buffer, pH 7'4, containing 1 gIl gelatine and 6 gIl NaC! and 100 JLI of tracer, equivalent to 66 pg of 3H-imipramine. The contents of the tube were mixed and incubated at room temperature for 30 min followed by S min on a cold tray. 100 JLl of dextran-eoated charcoal was added, the tubes were mixed, and after 10 min centrifuged at 2Soo rpm for 10 min. A 200 JLI aliquot of the supernatant was added to 4 ml of scintillation fluid and counted in an LKB Ultrabeta Liquid scintillation counter. One litre of scintillation fluid contained 667 rnl toluene, 333 rnl of triton X-loo, 4 g of PPO, and 0-1 g of POPOP.
Standards of amitriptyline and nortriptyline were prepared by dissolving their hydrochlorides in water (10 mg/rnl) and diluting in working buffer solution for use. They were stable for up to four weeks at 4°C. Other drugs were prepared in a similar manner.
CLINICAL STUDIES
Serum samples from patients who had received amitriptyline as part of their regular therapy for at least three weeks were taken and assayed for total drug.
On two occasions one volunteer, after overnight fasting, received SO mg of amitriptyline orally at 0900 hours after a light breakfast. Serum, saliva, and . . urine samples were taken at various times afterwards for up to 24 h. All samples were stored at -20°C before being analysed.
Results
IMMUNISATION RESPONSE
Only one of the three immunised sheep produced antibodies of sufficiently high titre to warrant further investigation. Antisera titres, measured as initial dilutions, showed significant increases in response to boosting doses of immunogen ( Fig. I ). Of the other two, one showed no response and the other showed a reduced response, about IO% of the first sheep. STANDARD CURVES 3H-imipramine was displaced from antibody binding sites by amitriptyline and nortriptyline but was more sensitive to amitriptyline ( Fig. 2A) . Thus, at a SO% binding of zero, 0·42 ng of amitriptyline was equivalent to 0·46 ng of nortriptyline in displacing 3H-imipramine. The average affinity Iconstants, as determined by Scatchard plots of the data, were 8·1 x 10 9 and 3·2 x 10 9 M-l for amitriptyline and nortriptyline respectively. If the diluent buffer was changed to glycine-alkali (O-OSM) of pH value 10'6, the nortriptyline curve was the more sensitive (Fig.  2B ), and 0'56 ng of amitriptyline was equivalent to 0·46 ng of nortriptyline. The addition of serum, saliva, or urine to the assay mixture had no significant effect on the standard curves.
Discussion
CLINICAL STUDIES
After an oral dose of amitriptyline the serum concentration of amitriptyline plus nortriptyline rose to a peak at 6 h ( Fig. 4) ; thereafter the serum concentration declined with a half-life of 11·8 h. Saliva samples taken at the same time as serum also showed a peak at 6 h, followed by a decline with a half-life of 12·8 h. Urine measurements showed that only 1 % of the administered dose was escreted as unmetabolised drug over 24 h.
The serum concentrations of amitriptyline plus nortriptyline in patients receiving different doses of amitriptyline are shown in Table 3 , andranged from 72 to 268 ngjmJ. In two of the patients studied, samples were taken at weekly intervals for three weeks. The concentrations of total drug for each sample were 142, 132, and 128 ngjml for one patient and 72, 70, and 72 ngjml for the other.
RECOVERIES
Recoveries of amitriptyline and nortriptyline added to serum averaged 115·7 ± 6·3 % and 104'3 ± 6·3 % (Table 2) over the concentration range 10-500 ngjml. Average recoveries of added drug from saliva over the same concentration range was 101·9 ± 7'9% and 100'5 ± 4·8 % respectively, and from urine over the concentration range 200-2000 ngjml was 119'3 ± 6·1 % and 103·9 ± 8·3 % respectively. Several samples obtained from patients taking amitriptyline were pooled and aliquoted for testing assay reproducibility. The within-assay and between-assay coefficients of variation for total drug were 5·5 % and 8·9% respectively at a concentration of 180 ngjml.
The validity of the RIA for amitriptyline plus nortriptyline was checked by a comparison of the results with those using GLe (Braithwaite and Widdop, 1971 ). The coefficient of correlation for 50 plasma samples measured by both methods was r = 0·99 (p < 0'01).
Many methods are available for the measurement of amitriptyline and nortriptyline in blood but none has gained widespread clinical use. Most require prior extraction and derivatisation of the compounds 
CROSS-REA C TIVITIES
Although the difference in cross-reactivity between amitriptyline and nortriptyline was not great, their metabolites cross-reacted by 10% or less ( Fig. 3) . Of the tricyclic compounds with a structure similar to amitriptyline, imipramine (82%), protriptyline (82%), and doxepin (100%) showed high crossreactivity, whereas-dothiepin (32%) and trimipramine (24 %) showed low cross-reactivity. Other centrally acting drugs belonging to different chemical classes showed negligible cross-reactivity (Table I) .
before measurement (eg, Braithwaite and Widdop, 1971) although other tricyclic compounds can be measured at the same time (Gifford et al., 1975; Connor et al., 1977) . A rapid, simple, and sensitive method would be useful for the routine measurement of these compounds, especially as there are large individual variations in the amount of drugs present in the body after their administration (Alexanderson et al., 1969) . We have used the RIA technique, described here, for this purpose. The procedure for the preparation of the immunogen has been used for methyl-amphetamine (Cheng et al., 1973) and propranolol (Marks et al., 1978) and, although the present immunogen was prepared using nortriptyline, the antiserum so produced was more sensitive to amitriptyline, although the difference was not marked. The only difference in structure of the two drugs is in the side chain, where amitriptyline has two methyl and nortriptylino one methyl group on the terminal N atom.
When the remaining methyl group is removed, as in G. P. Mould, G. Stout, G. Wynne Aherne, and V. Marks desmethyl-nortriptyline, the activity is reduced to 10% of amitriptyline. Other tricyclic compounds having a similar ring structure with only minor changes such as imipramine and protriptyline showed high cross-reactivity. Substitution in the ring, as in clomipramine or IO-hydroxyamitriptyline, or in the side chain, as in trimipramine, caused the cross-reactivity to fall to 11 %, 1 %, and 24 % respectively. These results indicate that an intact ring structure together with the dimethyl-aminopropyl side chain are important determinants for the antibody :antigen reaction.
The standard curve for amitriptyline, which was more sensitive than that of nortriptyline at a pH value of 7'4, became less sensitive at the higher pH value of 10·6. Little is known about the effect of pH on the antigen :antibody coupling, although Vader et al. (1977) showed that the binding of labelled angiotensin to antibody increased as the pH of the incubation mixture increased from 7'24 to 8'20.
The RIA is sensitive to 50 pg of added drug (0'5 ng/ml). This sensitivity is not normally required but may be useful in the measurement of salivary concentrations of the drug. Even 24 h after a single oral dose of 50 mg amitriptyline the saliva concentration was still measurable at 19 ng/rnl, It is easy to see how patient compliance can be monitored with the use of this assay.
We were able to measure serum concentrations of drug after a single oral dose in one subject and after long-term administration in patients receiving amitriptyline. The single dose kinetic study showed peak total drug serum concentrations at 6 h and an elimination half-life of 11·8 h. Saliva concentrations appeared to follow serum concentrations. Other workers have demonstrated various absorption patt~ms after single dose studies. For example, Robinson et al. (1977) showed the existence of secondary peaks, and Kaul and Whitfield (1975) found a single peak at 4 h although fewer serum samples were taken. The half-life of drug also varies considerably. Thus, Jergenson and Staehr (1976) calculated an elimination half-life of 15·1 h for amitriptyline on patients with long-term administration, whereas Braithwaite and Widdop (1971) had calculated a half-life of 41-45 h. Clearly more kinetic studies are needed to resolve some of these differences.
After long-term administration, however, there is a wide variation in plasma concentrations of amitriptyline and of nortriptyline between individual patients receiving these drugs (Alexanderson et al., 1969) . In our studies, four patients receiving the same dose showed only a 2'7-fold variation. A wider selection of patients may indicate a wider variation in serum concentrations of total drug. Individual variation in total drug serum concentrations once a steady state level has been achieved is small (Braithwaite and Widdop, 1971 ). This was demonstrated in our studies, where the variation in two patients over a three-week period was less than 10%. It is suggested that there may be a therapeutic range for the maximum effect of tricyclic drug (Asberg et al., 1971) . Recently, however, Coppen et al. (1978) could find no correlation between plasma concentration of amitriptyline and nortriptyline and clinical effect. Nevertheless most of their patients having high drug concentrations (> 200 ng/rnl) did not appear to respond to the drug. Ziegler et al. (1978) have shown that subjective side effects of nortriptyline correlated with elevated drug concentrations, and Montgomery et al. (1977) showed that those patients with high concentrations of drug responded poorly. Thus it may be that there is a specific sub-group of depressed patients who may be receiving too high a dose of drug and may therefore benefit from the monitoring of tricyclic drugs (Cooper et al., 1976; Nakra et al., 1977) . In those cases, the measurement of drug would enable the clinician to adjust the dosage to achieve a good therapeutic response.
The lack of specificity of the assay in some cases may be a disadvantage, but it is unlikely that more than one tricyclic antidepressant would be prescribed at the same time. In practice, the assay therefore demonstrates good specificity and, together with its sensitivity and simplicity, offers a considerable advantage over existing techniques.
